What Is The Growth Rate Of Global Single-Use Bioprocessing Market By 2028?

Single-use Bioprocessing Industry Overview

The global single-use bioprocessing market size was valued at USD 15.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 16.0% from 2021 to 2028. Advantages offered by Single-Use Technology (SUT), such as significant reduction in capital cost and facility construction time, have proliferated the use of disposables in the bioprocessing industry. This has resulted in the double-digit growth of the market for single-use bioprocessing.

Besides, despite the global economic loss due to the outbreak of the COVID-19 pandemic, the market experienced significant growth. Several CMOs and biomanufacturer have shifted their business focus to the production of therapeutics against SARS-CoV-2 infection using disposable technologies. in September 2020, Serum Institute selected ABEC’s Custom Single Run (CSR) technology to accelerate large-scale, single-use manufacturing of nearly 1.0 billion doses of Novavax vaccine which is designed against COVID-19.

Single-use Systems (SUS) are considered as a commercially viable approach to achieve maximum process efficiency and productivity by several end-users. As a result, SUS equipment is highly employed across the biomanufacturing phases, particularly in pre-commercial biopharmaceutical manufacturing. This has created opportunities for the product suppliers operating in the space.

Gather more insights about the market drivers, restrains and growth of the Global Single-use Bioprocessing market

Furthermore, the rising number of vendors offering robust disposables for commercial manufacturing of biopharmaceuticals is one of the major factors driving the market for single-use bioprocessing. Also, the introduction of automation in the bioprocessing industry has accelerated biomanufacturing efficiency exponentially. Big data analytics is anticipated to be the major trend in the near future.

The introduction of analytical models based on big data machine-learning is anticipated to result in improvement in product yields by enabling prediction and process parameters. Currently, the adoption of disposables is relatively higher among CMOs owing to the ease of use and efficiency of SUTs in bioprocessing of multiple products requiring fast turnaround times.

Browse through Grand View Research’s Biotechnology Industry Research Reports.

• Large & Small-Scale Bioprocessing Market – The global large & small-scale bioprocessing (biopharmaceutical manufacturing) market size was estimated at USD 26.12 billion in 2016. Bioprocess engineering has been effectively explored for the development of biopharmaceuticals and it has provided bio manufacturers and contract manufacturing organizations (CMO) with lucrative avenues of growth.

• Biopharmaceutical Third Party Logistics Market – The global biopharmaceutical third party logistics market size was estimated at USD 94.4 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.6% from 2021 to 2028. The rising trend of outsourcing logistics, the focus of pharmaceutical players on their distribution network owing to its strong sales numbers, and the rise in the number of biosimilar launches are some of the key factors driving the market.

Single-use Bioprocessing Market Segmentation

Grand View Research has segmented the global single-use bioprocessing market based on product, workflow, end-use, and region:

• Product Outlook (Revenue, USD Million, 2017 – 2028)
  • Simple & Peripheral Elements
    • Bags
    • Tubing, Filters, Connectors, & Transfer Systems
    • Sampling Systems
    • Probes & Sensors
      • pH Sensor
      • Oxygen Sensors
      • Pressure Sensors
      • Temperature Sensors
      • Conductivity Sensors
      • Flow Sensors
      • Other sensors
    • Others
  • Apparatus & Plants
    • Bioreactors, By Capacity
      • Up to 1000L
      • Above 1000L to 2000L
      • Above 2000L
    • Filtration system
    • Mixing, Storage, & Filling Systems 
    • Chromatography Systems
    • Pumps
    • Others
  • Work Equipment
    • Cell Culture System
    • Syringes
    • Others

• Workflow Outlook (Revenue, USD Million, 2017 – 2028)
  • Upstream
  • Fermentation
  • Downstream

• End-use Outlook (Revenue, USD Million, 2017 – 2028)
  • Biopharmaceutical Manufacturer
    • CMOs & CROs
    • In-house Manufacturer
  • Academic & Clinical Research Institutes

• Regional Outlook (Revenue, USD Million, 2017 – 2028)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Market Share Insights

• December 2020: Thermo Fisher Scientific introduced the HyPerforma DynaDrive Single-Use Bioreactor (SUB) with improved scalability and performance. This product supports large-scale cell culture processes.
• March 2020: GE Healthcare sold its Biopharma business to Danaher Corporation for approximately USD 20 billion in net cash. The biopharma unit is now named Cytiva.

Key Companies profiled:

Some prominent players in the global single-use bioprocessing market include

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Sartorius AG
• Corning Incorporated
• Pall Corporation
• General Electric Company (GE Healthcare)
• Eppendorf AG
• Rentschler Biopharma SE
• Lonza
• Meissner Filtration Products, Inc.
• JM BioConnect
• Boehringer Ingelheim GmbH
• Infors AG
• PBS Biotech, Inc.
• Entegris, Inc.
• Danaher Corporation
• Kuhner AG
• Rentschler Biopharma SE
  

Order a free sample PDF of the Single-use Bioprocessing Market Intelligence Study, published by Grand View Research.